Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv)

BSFV-046-100ug

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv)

A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

6648 €

BSFV-046-50ug

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv)

A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

3910.2 €

BSFV-077-100ug

Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv)

A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

6648 €

MBS140085-5x1mg

Recombinant Anti-Tetanus Toxoid scFv

31747.62 €

E21-A028-1

Recombinant anti-2019-nCoV NP ScFv

2019-nCoV ScFv Antibody

774.75 €

MBS8574824-005mg

Recombinant anti-2019-nCoV NP ScFv

1083.88 €